Tested Applications
| Positive FC detected in | human peripheral blood leukocyte |
Recommended dilution
| Application | Dilution |
|---|---|
| Flow Cytometry (FC) | FC : 20 ul per 10^6 cells in 100 μl suspension |
| This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 20 µl per 10^6 cells in a 100 µl suspension or 20 µl per 100 µl of whole blood. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
FITC-65183 targets CD34 in FC applications and shows reactivity with human, non-human primates samples.
| Tested Reactivity | human, non-human primates |
| Cited Reactivity | human |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
Human endothelial vesicles Predict reactive species |
| Full Name | CD34 molecule |
| Calculated Molecular Weight | 41 kDa |
| GenBank Accession Number | BC039146 |
| Gene Symbol | CD34 |
| Gene ID (NCBI) | 947 |
| RRID | AB_2883818 |
| Conjugate | FITC Fluorescent Dye |
| Excitation/Emission Maxima Wavelengths | 494 nm / 520 nm |
| Excitation Laser | Blue laser (488 nm) |
| Form | Liquid |
| Purification Method | The purified antibody is conjugated with fluorescein isothiocyanate (FITC) under optimum conditions. The conjugate is purified by size-exclusion chromatography. |
| UNIPROT ID | P28906 |
| Storage Buffer | PBS with 0.09% sodium azide, pH 7.3. |
| Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Publications
What published studies show
Based on the citation data retrieved for FITC-65183, here is the summary:
The antibody (catalog no. FITC-65183) has 6 total citations published across six journals: CNS & Neuroscience Therapeutics, Cells, Frontiers in Bioengineering and Biotechnology, Frontiers in Pharmacology, Molecular Medicine Reports, and Journal of Bioenergetics and Biomembranes. The associated research fields include mesenchymal stem cell (MSC) biology and characterization, cognitive impairment/neuroscience, ovarian cancer metastasis, bone regeneration, leukemia stem cells, and cardiomyocyte/neuronal differentiation. The cited application is flow cytometry (FC) in human samples.
Note: I was unable to retrieve the specific target/antibody name from our product database for this catalog number. If you could share the target name, I can verify further details.
| Species | Application | Title |
|---|---|---|
CNS Neurosci Ther hUC-MSCs via β-NGF Alleviate Cognitive Impairment After Tibial Fracture Surgery by Regulating the STMN2/NMNAT2-SARM1-NF-κB Signaling Pathway. | ||
Cells Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer | ||
Front Bioeng Biotechnol Self-assembled microtissues loaded with osteogenic MSCs for in vivo bone regeneration | ||
Front Pharmacol CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML. | ||
Mol Med Rep Ghrelin promotes cardiomyocyte differentiation of adipose tissue‑derived mesenchymal stem cells by DDX17‑mediated regulation of the SFRP4/Wnt/β‑catenin axis | ||
J Bioenerg Biomembr LNX2 involves in the role of ghrelin to promote the neuronal differentiation of adipose tissue-derived mesenchymal stem cells |
